Poland· PL-100093910
Kornam
A terazosin product containing terazosinum, registered in Poland by Sandoz GmbH. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Terazosin is registered in 12 of 19 countries.
Countries holding a registration under ATC G04CA03 (terazosin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Terazosin · ATC G04CA03
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of terazosin costs, country by country.
Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.19 in United States to $0.93 in Switzerland — a ×5.0 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Terazosin · price per daily dose (5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.93
- IT Italy$0.31
- US United States$0.19 (acquisition cost)
The record
At a glance
URPL (Poland)- Active substance
- Terazosinum
- Manufacturer
- Sandoz GmbH
- Country
- Poland (PL)
- ATC code
- G04CA03
- ATC class
- Terazosin
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
1 priced- gtin0590999048411930 szt.PLN 21.34
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
186 interactions on record for terazosin.
Graded by severity as the source publishes them — 72 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Terazosin · interactions on record
186 records
- 72 moderate
- 1 minor
- 112 info
Most severe, free to view
- ThiethylperazinA04AB03moderate
- DiphenhydraminA04AB05moderate
- DronabinolA04AD10moderate
- NabiloneA04AD11moderate
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Terazosin in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBenph 2mg tabletsViatris UK Healthcare Ltd
- ItalyITRINEBERLIFE FARMACEUTICI S.P.A.
- SpainTERAZOSINA CINFA 2 mg COMPRIMIDOS EFGLaboratorios Cinfa S.A.
- NetherlandsHytrin 2, tabletten 2 mgAmdipharm Limited
- CanadaAPO-TERAZOSINAPOTEX INC
- IrelandHytrin 2mg TabletsAmdipharm Limited
- NorwaySinalfaAmdipharm Limited
- SwedenSinalfa 2 mg TablettAmdipharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Austria · Uroflo, Vicard
- Belgium · Hytrin, Terazosab
- Czechia · Kornam
- Germany · Heitrin, Tera Tad
- Denmark · Sinalfa
- Spain · Alfaprost, Mayul
- France · Dysalfa, Hytrine
- United Kingdom (Northern Ireland) · Hytrin, Terazosin
- Greece · Hytrin
- Hungary · Setegis
- Ireland · Hytrin
- Italy · Itrin, Prostatil
- Luxembourg · Hytrin, Terazosab
- Netherlands · Hytrin, Terazosine Accord
- Norway · Sinalfa
- Portugal · Hytrin
- Sweden · Sinalfa
- Slovenia · Kornam
- Slovakia · Kornam
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0395e041-95fc-4cd8-985e-e726bfdc74c0 GET /v1/drugs/0395e041-95fc-4cd8-985e-e726bfdc74c0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "2 mg",
"packaging": "05909990484119 ¦ Rp ¦ 47988\n30 tabl.",
"substance": "Terazosini dihydricum hydrochloridum 2.374 mg",
"common_name": "Terazosinum",
"pl_product_id": "100093910",
"pozwolenie_nr": "04841",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about terazosin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.